Zobrazeno 1 - 10
of 16
pro vyhledávání: '"RU-BO CAO"'
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundFor patients with anaplastic thyroid cancer (ATC) without mutational driver genes, chemotherapy is suggested to be the first-line treatment option. However, the benefits of chemotherapy in treating ATC are limited. In this analysis, we coll
Externí odkaz:
https://doaj.org/article/251e2e7c0f9f4df4987a09cde7f50c48
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundTyrosine kinase inhibitors (TKIs) contribute to the treatment of patients with anaplastic thyroid cancer (ATC). Although prospective clinical studies of TKIs exhibit limited efficacy, whether ATC patients benefit from TKI treatment in real-
Externí odkaz:
https://doaj.org/article/e369634cb7b840cb962a6c6dded54602
Publikováno v:
Cancer Medicine, Vol 8, Iss 13, Pp 5969-5978 (2019)
Abstract Background Inhibitors of programmed cell death‐1 (PD‐1) and its ligand (PD‐L1) have been increasingly used in head and neck cancer therapy and reported to improve the outcomes with an acceptable safety profile. This systematic review a
Externí odkaz:
https://doaj.org/article/bc05e3877b66412094804d662bec26b9
Publikováno v:
Medicine; 8/2/2024, Vol. 103 Issue 31, p1-6, 6p
Autor:
Wang Bing Chen, Quentin Liu, Xiao Jun Qian, Chen Fu, Bi-Cheng Wang, Yun Tian Li, Guo He Lin, Ru Bo Cao, Pin Dong Li
Publikováno v:
Oral oncology. 104
Objectives There is currently no effective salvage therapeutic modality that improves the survival outcomes of patients with recurrent or metastatic nasopharyngeal carcinoma. However, the programmed cell death protein 1 (PD-1) and its ligand (PD-L1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2749b1ab811301dd8dd32cde6f8fad5
https://pubmed.ncbi.nlm.nih.gov/32182550
https://pubmed.ncbi.nlm.nih.gov/32182550
Autor:
Jian‑Li Hu, Shi Jiang Fei, Ru Bo Cao, Qian Ding, Gang Peng, Yao Jiang, Jing Wang, Wen-Jie Zhang, Gang Wu, Pengcheng Li, Ruo Zheng Wang, Pin Dong Li, Kun Yu Yang
Publikováno v:
Oncology Letters. 9:2515-2519
The present study aimed to characterize the expression of Krüppel-like factor 8 (KLF8) in nasopahryngeal carcinoma (NPC) cell lines and determine its effect on tumor development and invasion following KLF8 gene knockdown by small hairpin RNA (shRNA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f9c1e4558ee6168137422f12b5d9217
https://doi.org/10.3892/ol.2015.3099
https://doi.org/10.3892/ol.2015.3099
Autor:
GANG PENG1, RU-BO CAO1, YUE-HUA LI1, ZHEN-WEI ZOU1, JING HUANG1, QIAN DING1 dingqian75@163.com
Publikováno v:
Molecular Medicine Reports. 2014, Vol. 10 Issue 4, p1709-1716. 8p.
Autor:
Jing Chen, Charlie Ma, Li-Li Chen, Ru-Bo Cao, Pindong Li, Hong Ma, Jing Yao, Wen-Jie Zhang, Jianli Hu, Kun-Yu Yang, Tian-Tian Cheng, Gang Wu
Publikováno v:
Oncotarget
// Pin-Dong Li 1, 2, * , Jian-Li Hu 1, * , Charlie Ma 2 , Hong Ma 1 , Jing Yao 1 , Li-Li Chen 2 , Jing Chen 1 , Tian-Tian Cheng 3 , Kun-Yu Yang 1 , Gang Wu 1 , Wen-Jie Zhang 4 and Ru-Bo Cao 1 1 Cancer Center, Union Hospital, Tongji Medical College, H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee4a5729b80e063fb6f1bd93ccd4b580
https://pubmed.ncbi.nlm.nih.gov/28404954
https://pubmed.ncbi.nlm.nih.gov/28404954
Autor:
Xiang Fang Dai, Peng Cheng Li, Ting Liu, Ru Bo Cao, Shi Jiang Fei, Zhen Wei Zou, Jian Li Hu, Hong Ge Wu, Kun Yu Yang, Gang Wu, Pin Dong Li, Qian Ding, Wen-Jie Zhang, Gang Peng
Publikováno v:
Oncology reports. 32(6)
Progestin and adipoQ receptor family member III (PAQR3) is a regulator that negatively modulates the Ras/Raf/MEK/ERK signaling cascade and the GPCR Gβγ subunit signaling pathway. The role of PAQR3 in hepatocellular carcinoma (HCC) has not been eluc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6f6eeabbf9685ad224a8866588fd196
https://pubmed.ncbi.nlm.nih.gov/25310770
https://pubmed.ncbi.nlm.nih.gov/25310770
Autor:
JING WANG, JIAN LI HU, RU BO CAO, QIAN DING, GANG PENG, SHI JIANG FEI, YAO JIANG, PENG CHENG LI, KUN YU YANG, WEN JIE ZHANG, GANG WU, RUO ZHENG WANG, PIN DONG LI
Publikováno v:
Oncology Letters; 2015, Vol. 9 Issue 6, p2515-2519, 5p